126202002: Levothyroxine sodium (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Thyroid hormone\Levothyroxine sodium

\Drug or medicament (substance)\Hormone\Thyroid hormone\Levothyroxine sodium

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Levothyroxine sodium	Is a	Thyroxine	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium	Is a	Levothyroxine (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium	Has disposition	Thyroid hormone (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium	Is modification of (attribute)	Levothyroxine (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium	Is a	Thyroid hormone	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium	Is a	Hormone	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium	Is a	allergène médicamenteux	false	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing levothyroxine sodium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 25mcg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 50mcg tablet (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 100mcg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 150mcg tablet (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely levothyroxine sodium 175 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely levothyroxine sodium 200 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely levothyroxine sodium 300 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely levothyroxine sodium 88 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 112mcg tablet (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 137 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 250 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 0.05mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 0.075mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 0.088mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 0.1mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 0.112mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 0.15mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 0.175mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 0.125mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 0.2mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 0.3mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium o.05mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 0.15mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 0.025mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 200mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely levothyroxine sodium 125 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium + liothyronine sodium 100mcg/25mcg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Laevothyroxine sodium + liothyronine sodium 50mcg/12.5mcg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Liotrix preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing levothyroxine sodium and liothyronine sodium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
intoxication accidentelle par la lévothyroxine sodique	Causative agent (attribute)	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
intoxication intentionnelle par la lévothyroxine sodique	Causative agent (attribute)	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
intoxication par la lévothyroxine sodique d'intention indéterminée	Causative agent (attribute)	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
intoxication par la lévothyroxine sodique	Causative agent (attribute)	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely levothyroxine sodium 50 microgram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely levothyroxine sodium 125 microgram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing levothyroxine sodium in oral dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)
Levothyroxine sodium 25mcg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levothyroxine sodium 25mcg tablet	Has basis of strength substance (attribute)	True	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levothyroxine sodium 50mcg tablet (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levothyroxine sodium 50mcg tablet (product)	Has basis of strength substance (attribute)	True	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levothyroxine sodium 100mcg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levothyroxine sodium 100mcg tablet	Has basis of strength substance (attribute)	True	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levothyroxine sodium 150mcg tablet (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levothyroxine sodium 150mcg tablet (product)	Has basis of strength substance (attribute)	True	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 175 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 175 microgram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 200 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 200 microgram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 300 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 300 microgram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 88 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 88 microgram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levothyroxine sodium 112mcg tablet (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levothyroxine sodium 112mcg tablet (product)	Has basis of strength substance (attribute)	True	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levothyroxine sodium 137 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levothyroxine sodium 137 microgram oral tablet	Has basis of strength substance (attribute)	True	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levothyroxine sodium 250 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levothyroxine sodium 250 microgram oral tablet	Has basis of strength substance (attribute)	True	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 125 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 125 microgram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	True	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Levothyroxine sodium + liothyronine sodium 100mcg/25mcg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Levothyroxine sodium + liothyronine sodium 100mcg/25mcg tablet	Has basis of strength substance (attribute)	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Laevothyroxine sodium + liothyronine sodium 50mcg/12.5mcg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Laevothyroxine sodium + liothyronine sodium 50mcg/12.5mcg tablet	Has basis of strength substance (attribute)	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 50 microgram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 50 microgram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 25 microgram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 100 microgram/1 each conventional release oral capsule	Has basis of strength substance (attribute)	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 125 microgram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 125 microgram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet	Has basis of strength substance (attribute)	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Laevothyroxine sodium + liothyronine sodium 50mcg/12.5mcg tablet	Has basis of strength substance (attribute)	True	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely levothyroxine sodium 75 microgram/1 each conventional release oral capsule	Has precise active ingredient	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely levothyroxine sodium 150 microgram/1 each conventional release oral capsule	Has precise active ingredient	False	Levothyroxine sodium	Inferred relationship	Existential restriction modifier (core metadata concept)	1

Page 1 of 2 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
32188019	Levothyroxine sodium	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
730135010	Levothyroxine sodium (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
32188019	Levothyroxine sodium	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
32188019	Levothyroxine sodium	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
473650019	Laevothyroxine sodium	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
730135010	Levothyroxine sodium (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
730135010	Levothyroxine sodium (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3005911018	Thyroxine sodium	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
820761000172117	lévothyroxine sodique	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
820761000172117	lévothyroxine sodique	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module